Long-term Follow Up of Patients Previously Enrolled in MC1137 (BEAUTY)

Overview

About this study

The purpose of this study is to extend the follow up on the BEAUTY study (MC1137) cohort and collect additional blood samples to evaluate for minimal residual disease and tissue at the time of any breast cancer recurrence.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* REGISTRATION - FOR PATIENTS STILL ALIVE:
* Enrolled in BEAUTY (MC1137 \[NCT02022202\]) and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up
* Able to provide written informed consent
* Willingness to provide mandatory blood specimens for future research on breast cancer at Mayo Clinic
* Willingness to provide mandatory tissue specimens for future research on breast cancer at Mayo Clinic
* Willingness to provide consent for use of archived tumor biopsies obtained after enrollment in BEAUTY (Request tissue from prior biopsy of site of recurrence)
* Ability to complete questionnaires by themselves or with assistance
* REGISTRATION - FOR PATIENTS WHO HAVE DIED:
* Enrolled in MC1137 and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up
* Existence of a family member willing to provide consent for use of archived tumor biopsies obtained after enrollment in BEAUTY

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/20/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Donald Northfelt, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Jacksonville, Fla.

Mayo Clinic principal investigator

Sarah McLaughlin, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Rochester, Minn.

Mayo Clinic principal investigator

Judy Boughey, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions